122 related articles for article (PubMed ID: 7973321)
21. Sleepless in America.
Gorman C
Time; 2001 Dec; 158(26):88. PubMed ID: 11778569
[No Abstract] [Full Text] [Related]
22. Methylphenidate: a review of its neuropharmacological, neuropsychological and adverse clinical effects.
Leonard BE; McCartan D; White J; King DJ
Hum Psychopharmacol; 2004 Apr; 19(3):151-80. PubMed ID: 15079851
[No Abstract] [Full Text] [Related]
23. Low-resolution brain electromagnetic tomography (LORETA) identifies brain regions linked to psychometric performance under modafinil in narcolepsy.
Saletu M; Anderer P; Semlitsch HV; Saletu-Zyhlarz GM; Mandl M; Zeitlhofer J; Saletu B
Psychiatry Res; 2007 Jan; 154(1):69-84. PubMed ID: 17187965
[TBL] [Abstract][Full Text] [Related]
24. Impact of drug regulations and diversion control systems on legitimate narcolepsy patients.
Piscopo JA
NIDA Res Monogr; 1993; 131():249-59. PubMed ID: 8105384
[No Abstract] [Full Text] [Related]
25. Management of narcolepsy during pregnancy.
Thorpy M; Zhao CG; Dauvilliers Y
Sleep Med; 2013 Apr; 14(4):367-76. PubMed ID: 23433999
[TBL] [Abstract][Full Text] [Related]
26. [Narcolepsy in children].
Martínez-Salcedo E; Lloret-Sempere T; García-Navarro M; Sellés-Gallana MF
Rev Neurol; 2001 Dec 1-15; 33(11):1049-53. PubMed ID: 11785033
[TBL] [Abstract][Full Text] [Related]
27. The nightly administration of sodium oxybate results in significant reduction in the nocturnal sleep disruption of patients with narcolepsy.
Black J; Pardi D; Hornfeldt CS; Inhaber N
Sleep Med; 2009 Sep; 10(8):829-35. PubMed ID: 19616998
[TBL] [Abstract][Full Text] [Related]
28. Effects of dextroamphetamine, caffeine and modafinil on psychomotor vigilance test performance after 44 h of continuous wakefulness.
Killgore WD; Rupp TL; Grugle NL; Reichardt RM; Lipizzi EL; Balkin TJ
J Sleep Res; 2008 Sep; 17(3):309-21. PubMed ID: 18522689
[TBL] [Abstract][Full Text] [Related]
29. [Modafinil: pharmacology and therapeutic perspectives].
Billiard M
Rev Neurol (Paris); 2003 Jan; 159(1):122-5. PubMed ID: 12618664
[No Abstract] [Full Text] [Related]
30. The efficacy and safety of armodafinil as treatment for adults with excessive sleepiness associated with narcolepsy.
Harsh JR; Hayduk R; Rosenberg R; Wesnes KA; Walsh JK; Arora S; Niebler GE; Roth T
Curr Med Res Opin; 2006 Apr; 22(4):761-74. PubMed ID: 16684437
[TBL] [Abstract][Full Text] [Related]
31. Day case general anaesthesia in a patient with narcolepsy.
Doyle A; Wilkinson D
Anaesthesia; 2008 Aug; 63(8):880-2. PubMed ID: 18518866
[TBL] [Abstract][Full Text] [Related]
32. Alerting drugs: do they really work?
Mitler MM
Psychopharmacol Bull; 1987; 23(3):435-9. PubMed ID: 2893422
[No Abstract] [Full Text] [Related]
33. Fragmentation of sleep-wake cycle secondary to narcolepsy and Cheyne-Stokes respiration.
Cormican LJ; Williams AJ
Sleep Med; 2005 Jan; 6(1):87-8. PubMed ID: 15680304
[No Abstract] [Full Text] [Related]
34. Fibrositis syndrome and narcolepsy.
Disdier P; Genton P; Milandre C; Bernard PM; Millet Y
J Rheumatol; 1993 May; 20(5):888-9. PubMed ID: 8101569
[TBL] [Abstract][Full Text] [Related]
35. [Gammahydroxybutyrate must remain available for patients with narcolepsy].
Lammers GJ; van Dijk JG; Ferrari MD; van Gerven JM; Declerck AC; Troost J
Ned Tijdschr Geneeskd; 1999 Oct; 143(41):2062-3. PubMed ID: 10560549
[TBL] [Abstract][Full Text] [Related]
36. Narcolepsy: action of two gamma-aminobutyric acid type B agonists, baclofen and sodium oxybate.
Huang YS; Guilleminault C
Pediatr Neurol; 2009 Jul; 41(1):9-16. PubMed ID: 19520267
[TBL] [Abstract][Full Text] [Related]
37. The neurobiology, diagnosis, and treatment of narcolepsy.
Scammell TE
Ann Neurol; 2003 Feb; 53(2):154-66. PubMed ID: 12557281
[TBL] [Abstract][Full Text] [Related]
38. Narcolepsy in the custodial setting.
Wall IF
J Clin Forensic Med; 2005 Oct; 12(5):274-6. PubMed ID: 16198971
[TBL] [Abstract][Full Text] [Related]
39. [Modafinil in narcolepsy. A new therapeutic principle proves successful].
Nervenarzt; 2000 Jan; 71(1 Suppl Ein Neues):1-4. PubMed ID: 10696307
[No Abstract] [Full Text] [Related]
40. [Apropos the National Board and Welfare's report on ADDH: some views on the treatment with central nervous system stimulants].
Zetterström R
Lakartidningen; 2002 Aug; 99(35):3435-6. PubMed ID: 12362770
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
